LinkedIn·Wednesday, 12 August 2026·14d ago

"We have the PBMCs, is TCR sequencing really worth it?" I am definitely biased but TCR sequencing brings a lot of extra value to the table.…

Tom Bosschaerts

Annotate the epitope specificity of your T-cell receptors | 🔎 ImmuneWatch

"We have the PBMCs, is TCR sequencing really worth it?" I am definitely biased but TCR sequencing brings a lot of extra value to the table. Thinks like T cell diversity, whether they are expanding, or contracting over time, what they might be reacting to, ... Real evidence in response to a treatment. To get more of that analysis done, we teamed up with QIAGEN to fund the full workflow for up to 4 projects, 2 academic and 2 biopharma: 1) QIAGEN's RNA extraction kit, shipped directly to the lab 2) QIAseq Targeted RNA TCR Panel library prep 3) Full NGS sequencing and clonotype processing 4) TCR clustering and antigen-TCR annotation from our own DETECT analysts Up to 24 samples per award, wrapped up within 6 months. Applications close 30 October 2026. On 2 September we're running a webinar on the grant and on how we usually approach TCR sequencing analysis. What would your own T cells tell you if the sequencing was free? https://tally.so/r/zxAv90